MedTrace Logo

Effect of Oral Magnesium Therapy on Constipation on Cerebral Palsy Children

NCT03471312 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-03-20

No results posted yet for this study

Summary

The aim of this study is to study the therapeutic and adverse effects of oral magnesium sulfate therapy on constipation in children with spastic cerebral palsy suffering from chronic constipation in neuro pediatric unit at Assiut University Hospital.

Conditions

  • Magnesium Therapy on Cerebral Palsy Patients

Interventions

DRUG

Magnesium

magnesium therapy

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2018-10-30
Completion
2018-12-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03471312 on ClinicalTrials.gov